Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous NK Cell”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Early research (Phase 1)Study completedNCT02271711
What this trial is testing

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Who this might be right for
Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
M.D. Anderson Cancer Center 12
Large-scale testing (Phase 3)Looking for participantsNCT07678229
What this trial is testing

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Rong Tao 150
Testing effectiveness (Phase 2)WithdrawnNCT03003728
What this trial is testing

2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)

Who this might be right for
Multiple Myeloma
University of Arkansas
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948994
What this trial is testing

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

Who this might be right for
NeuroblastomaGD2 AntibodyAutologous NK Cell
Guangzhou Women and Children's Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT01655628
What this trial is testing

GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Stage IV Nasopharyngeal Carcinoma
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT01894373
What this trial is testing

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Who this might be right for
PsoriasisAdoptive Immunotherapy
Chinese PLA General Hospital 10
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Testing effectiveness (Phase 2)UnknownNCT02030561
What this trial is testing

NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer

Who this might be right for
Breast CancerGastric Cancer
National University Hospital, Singapore 29
Early research (Phase 1)UnknownNCT04480788
What this trial is testing

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Who this might be right for
T Lymphoblastic Leukemia/LymphomaExtramedullary NK-T-cell Lymphoma, Nasal TypePeripheral T-cell Lymphoma, Nonspecific+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 9
Not applicableStudy completedNCT00536601
What this trial is testing

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+56 more
Roswell Park Cancer Institute 174
Early research (Phase 1)Study completedNCT02481934
What this trial is testing

Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Joaquín Martínez López, MD, PhD 5
Testing effectiveness (Phase 2)UnknownNCT02370017
What this trial is testing

Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment

Who this might be right for
Non-small Cell Lung Cancer
The Catholic University of Korea 68
Testing effectiveness (Phase 2)UnknownNCT03789617
What this trial is testing

A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

Who this might be right for
EBV Associated Extranodal NK/T-cell LymphomaEBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
Eutilex 72
Early research (Phase 1)UnknownNCT02882659
What this trial is testing

Dendritic Killer Cell-based Immunotherapy for Solid Tumors

Who this might be right for
Colorectal NeoplasmsHepatocellular CarcinomaNeoplasm Metastasis
FullHope Biomedical Co., Ltd. 18
Very early researchUnknownNCT03662477
What this trial is testing

Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation

Who this might be right for
NK Cell Mediated Immunity
Shenzhen Fifth People's Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00394381
What this trial is testing

Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome, High Grade
Singapore General Hospital 17
Testing effectiveness (Phase 2)UnknownNCT01178658
What this trial is testing

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Seoul National University Hospital 42
Testing effectiveness (Phase 2)UnknownNCT02215837
What this trial is testing

Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer

Who this might be right for
Gastric CancerNeoplasmsGastrointestinal Neoplasms+2 more
Shenzhen Hornetcorn Bio-technology Company, LTD 40
Testing effectiveness (Phase 2)UnknownNCT02725996
What this trial is testing

By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy

Who this might be right for
Hepatocellular Carcinoma
Southwest Hospital, China 140
Testing effectiveness (Phase 2)UnknownNCT03987698
What this trial is testing

Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 90
Next Page